Synthesis of protopanaxadiol derivatives and evaluation of their anticancer activities

Anti-Cancer Drugs

Volumn 22, Issue 1, 2011, Pages 35-45

  Du, Guang Jian ^a,b   Dai, Qing ^b   Williams, Stainley ^a   Wang, Chong Zhi ^a,b   Yuan, Chun Su ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

apoptosis; cell cycle; colon cancer; protopanaxadiol derivatives; semisynthesis

Indexed keywords

24 CYCLOPROPANE PROTOPANAXADIOL; 24,25 DIHYDROXYLPROTOPANAXADIOL; 3 ACETIC ACID 12 OXOHEPTAN PROTOPANAXADIOL; 3 ACETIC ACID 24 CYCLOPROPANE PROTOPANAXADIOL; 3 ACETIC ACID PROTOPANAXADIOL; 3,12 DIACETIC ACID PROTOPANAXADIOL; 3,12 DIACETIC ACID, 24 METHANESULFONYL, 25 HYDROXYLPROTOPANAXADIOL; 3,12 DIACETIC ACID, 24 OXOHEPTAN PROTOPANAXADIOL; 3,12 DIACETIC ACID, 24,25 DIHYDROXYLPROTOPANAXADIOL; ANTINEOPLASTIC AGENT; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PARTIAL DRUG SYNTHESIS; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; G1 PHASE; HCT116 CELLS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PANAX; SAPOGENINS; SAPONINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78650509813     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32833fde29     Document Type: Article

References (25)

1. American Cancer Society. Cancer facts and figures 2009. Atlanta, GA: American Cancer Society; 2010.
2. Newman DJ, Cragg GM. Natural products as sources of new drugs over the last 25 years. J Nat Prod 2007; 70:461-477.
3. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286:208-216.
4. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: An analysis of 25 preparations. Am J Clin Nutr 2001; 73:1101-1106.
5. Wang CZ, Zhang B, Song WX, Wang A, Ni M, Luo X, et al. Steamed American ginseng berry: Ginsenoside analyses and anticancer activities. J Agric Food Chem 2006; 54:9936-9942.
6. Xie JT, Wang CZ, Li XL, Ni M, Fishbein A, Yuan CS. Anti-diabetic effect of American ginseng may not be linked to antioxidant activity: Comparison between American ginseng and Scutellaria baicalensis using an ob/ob mice model. Fitoterapia 2009; 80:306-311.
7. Kim TH, Lee YS, Cho CK, Park S, Choi SY, Yool SY. Protective effect of ginseng on radiation-induced DNA double strand breaks and repair in murine lymphocytes. Cancer Biother Radiopharm 1996; 11:267-272.
8. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 1999; 58:1685-1693.
9. Lee SH, Seo GS, Ko G, Kim JB, Sohn DH. Anti-inflammatory activity of 20(S)-protopanaxadiol: Enhanced heme oxygenase 1 expression in RAW 264.7 cells. Planta Med 2005; 71:1167-1170.
10. Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chem Rev 2009; 109:3012-3043.
11. Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res 2009; 55:1-99.
12. Wang CZ, Aung HH, Zhang B, Sun S, Li XL, He H, et al. Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells. Anticancer Res 2008; 28:2545-2551.
13. Wang CZ, Yuan CS. Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 2008; 36:1019-1028.
14. Yun TK, Choi SY. Preventive effect of ginseng intake against various human cancers: A case-control study on 1987 pairs. Cancer Epidemiol Biomarkers Prev 1995; 4:401-408.
15. Yun TK, Choi SY. Non-organ specific cancer prevention of ginseng: A prospective study in Korea. Int J Epidemiol 1998; 27:359-364.
16. Shibata S, Tanaka O, Ando T, Sado M, Tsushima S, Ohsawa T. Chemical studies on oriental plant drugs. XIV. Protopanaxadiol, a genuine sapogenin of ginseng saponins. Chem Pharm Bull (Tokyo) 1966; 14:595-600.
17. Nagai Y, Tanaka O, Shibata S. Chemical studies on the oriental plant drugs-XXIV: Structure of ginsenoside-Rg1, a neutral saponin of ginseng root. Tetrahedron 1971; 27:12.
18. Usami Y, Liu YN, Lin AS, Shibano M, Akiyama T, Itokawa H, et al. Antitumor agents. 261. 20(S)-Protopanaxadiol and 20(S)-protopanaxatriol as antiangiogenic agents and total assignment of (1)H NMR spectra. J Nat Prod 2008; 71:478-481.
19. Bai Y, Zhao L, Qu C, Meng X, Zhang H. Microwave degradation of floatationenriched ginsenoside extract from Panax quinquefolium L. leaf. J Agric Food Chem 2009; 57:10252-10260.
20. Wang W, Rayburn ER, Zhao Y,Wang H, Zhang R. Novel ginsenosides 25- OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: Anticancer activity and mechanisms of action. Cancer Lett 2009; 278:241-248.
21. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. In vitro anticancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 2007; 59:589-601.
22. Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004; 9:259-274.
23. Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals: Active constituents and their potential role in cardiovascular illness. Am J Chin Med 2007; 35:543-558.
24. Koo HN, Jeong HJ, Choi IY, An HJ, Moon PD, Kim SJ, et al. Mountain grown ginseng induces apoptosis in HL-60 cells and its mechanism have little relation with TNF-alpha production. Am J Chin Med 2007; 35:169-182.
25. Ho YS, Wu CH, Chou HM, Wang YJ, Tseng H, Chen CH, et al. Molecular mechanisms of econazole-induced toxicity on human colon cancer cells: G0/G1 cell cycle arrest and caspase 8-independent apoptotic signaling pathways. Food Chem Toxicol 2005; 43:1483-1495.